Systemic lupus erythematosus and chronic myeloid leukemia: mere coexistence or association?
Rudrajit Paul, Jayanti Ray, Babulal Daulagajao, Rojina Choudhury, Sanjoy Bhattacharya
DOI: 10.7324/JAPS.2014.41117Pages: 098-100
Non-hematological Adverse Events of Imatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Mehrdad Payandeh, Edris Sadeghi, Masoud Sadeghi
DOI: 10.7324/JAPS.2015.50213Pages: 087-090
Sorafenib combination with imatinib enhances apoptotic and cell cycle arrest effects with no effect on viability and BCR-ABL expression of K-562 cells
Belal A. Al-Husein, Ahmad Al-Azayzih, Fatema S. Redha
DOI: 10.7324/JAPS.2024.161424Pages:
